Möbus, V., & Schneeweiss, A. (2016). Abstract P1-13-05: GAIN-2: Adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients with high-risk early breast cancer: Results of the second safety interim analyses. Cancer research, 76(4), . https://doi.org/10.1158/1538-7445.SABCS15-P1-13-05
Chicago-Zitierstil (17. Ausg.)Möbus, Volker, und Andreas Schneeweiss. "Abstract P1-13-05: GAIN-2: Adjuvant Phase III Trial to Compare Intense Dose-dense (idd) Treatment with EnPC to Tailored Dose-dense (dt) Therapy with DtEC-dtD for Patients with High-risk Early Breast Cancer: Results of the Second Safety Interim Analyses." Cancer Research 76, no. 4 (2016). https://doi.org/10.1158/1538-7445.SABCS15-P1-13-05.
MLA-Zitierstil (9. Ausg.)Möbus, Volker, und Andreas Schneeweiss. "Abstract P1-13-05: GAIN-2: Adjuvant Phase III Trial to Compare Intense Dose-dense (idd) Treatment with EnPC to Tailored Dose-dense (dt) Therapy with DtEC-dtD for Patients with High-risk Early Breast Cancer: Results of the Second Safety Interim Analyses." Cancer Research, vol. 76, no. 4, 2016, https://doi.org/10.1158/1538-7445.SABCS15-P1-13-05.